Literature DB >> 2291657

Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery.

C Martin1, B Bruguerolle, M N Mallet, M Condomines, B Sastre, F Gouin.   

Abstract

Levels in serum and tissue penetration of ornidazole were studied after a single intravenous injection of 1,000 mg given to 14 patients for prophylaxis of surgical infection. They were scheduled for elective colorectal surgery. Adequate levels in blood (greater than or equal to MIC for 90% of Bacteroides fragilis strains tested) were found in all patients throughout the procedure and up to hour 24. Mean-maximal (15 min) and last-determined (24 h) ornidazole levels in serum were 24 +/- 5.2 and 6.3 +/- 1.4 mg/liter, respectively. beta-Phase elimination half-life was 14.1 +/- 2.7 h, and clearance and apparent volume of distribution were 47 +/- 12 ml/min and 0.9 +/- 0.13 liters/kg, respectively. In all patient, adequate levels in tissue were found in the abdominal wall and the epiploic fat at time of incision and in the colonic wall at time of anastomosis. At time of closure, all but one patient had adequate levels in tissue in the abdominal wall and the epiploic fat. No anaerobic nor aerobic infection occurred in the study patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2291657      PMCID: PMC171965          DOI: 10.1128/AAC.34.10.1921

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  The importance of tissue antibiotic activity in the prevention of operative wound infection.

Authors:  T M Bergamini; H C Polk
Journal:  J Antimicrob Chemother       Date:  1989-03       Impact factor: 5.790

2.  The effective period of preventive antibiotic action in experimental incisions and dermal lesions.

Authors:  J F Burke
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

3.  Preoperative prophylactic cephalothin fails to control septic complications of colorectal operations: results of controlled clinical trial. A Veterans Administration cooperative study.

Authors:  R E Condon; J G Bartlett; R L Nichols; W J Schulte; S L Gorbach; S Ochi
Journal:  Am J Surg       Date:  1979-01       Impact factor: 2.565

4.  Gentamicin levels in the human biliary tract.

Authors:  H A Pitt; R B Roberts; W D Johnson
Journal:  J Infect Dis       Date:  1973-03       Impact factor: 5.226

5.  Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens.

Authors:  J E Conte; S N Cohen; B B Roe; R M Elashoff
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

Review 6.  Antimicrobial prophylaxis in surgery.

Authors:  A B Kaiser
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

7.  Tinidazole in the prevention of wound infection after elective colorectal surgery.

Authors:  P S Hunt; J K Francis; G Peck; K Farrell; A Sali
Journal:  Med J Aust       Date:  1979-02-24       Impact factor: 7.738

8.  The effect of metronidazole on the incidence of postoperative wound infection in elective colon surgery.

Authors:  C Brass; G K Richards; J Ruedy; J Prentis; E J Hinchey
Journal:  Am J Surg       Date:  1978-01       Impact factor: 2.565

9.  Prophylaxis against anaerobic sepsis in bowel surgery.

Authors:  M R Keighley; A R Crapp; D W Burdon; W T Cooke; J Alexander-Williams
Journal:  Br J Surg       Date:  1976-07       Impact factor: 6.939

10.  Pharmacokinetics of ornidazole in patients with severe liver cirrhosis.

Authors:  A M Taburet; F Delion; P Attali; J J Thebault; E Singlas
Journal:  Clin Pharmacol Ther       Date:  1986-09       Impact factor: 6.875

View more
  7 in total

Review 1.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

2.  Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation.

Authors:  A Steib; B Jacoberger; M Von Bandel; F Beck; J P Beller; K Boudjema; J C Koffel; J C Otteni
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  Non-observance of guidelines for surgical antimicrobial prophylaxis and surgical-site infections.

Authors:  S Lallemand; M Thouverez; P Bailly; X Bertrand; D Talon
Journal:  Pharm World Sci       Date:  2002-06

Review 4.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

5.  Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery.

Authors:  C Martin; B Sastre; M N Mallet; B Bruguerolle; J P Brun; P De Micco; F Gouin
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

6.  A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis.

Authors:  Jyoti Thulkar; Alka Kriplani; Nutan Agarwal
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

7.  In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes.

Authors:  Qi Xin; Miaomiao Yuan; Huanping Li; Xiaoxia Song; Jun Lu; Tao Jing
Journal:  Vet Res       Date:  2019-11-19       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.